Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advanced Medical Isotope or AMIC, a developer and distributor of medical isotopes, has said that it will partner with the US Department of Energy, through the Pacific Northwest National Laboratory on a two-year project with the Kharkiv Institute of Physics and Technology in Ukraine, to develop and bring to market an innovative compact-systems technology for producing new medical isotopes.
Subscribe to our email newsletter
The Global Initiatives for Proliferation Prevention (GIPP) program under Department of Energy’s National Nuclear Security Administration (NNSA) and AMIC will each contribute $760,000 to the project.
The new production method funded by this project is based on the alternative method for producing medical isotopes (AMPMI) technology being developed at the Kharkiv Institute. The AMPMI method generates an intense neutron beam at high fluence rate under controlled conditions, with an advanced target design for efficient production of neutron-rich medical isotopes.
Jim Katzaroff, CEO at AMIC, said: The AMPMI neutron technology complements our current proton LINAC at our first production facility in Kennewick, Washington. We anticipate that the AMPMI neutron technology will provide the opportunity to produce a wide variety of medical isotopes on a smaller scale, closer to the point of use, than isotope production in nuclear reactors.